Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2013-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.taap.2013.08.023PMID 23999542PMCID PMC4484623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Modulation by Delta9-Tetrahydrocannabinol (∆9-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4+ T cells

  2012cited by this paper
• Janus kinase deregulation in leukemia and lymphoma.

  2012cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2-Glycerol, a Putative Metabolite of 2-Arachidonyl Glycerol and a Peroxisome Proliferator-Activated Receptor γ Ligand, Modulates Nuclear Factor of Activated T Cells

  2012cited by this paper
• Magnitude of stimulation dictates the cannabinoid‐mediated differential T cell response to HIVgp120

  2012cited by this paper
• Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

  2011cited by this paper
• CpG and Non-CpG Oligodeoxynucleotides Directly Costimulate Mouse and Human CD4+ T Cells through a TLR9- and MyD88-Independent Mechanism

  2011cited by this paper
• An enigmatic tail of CD28 signaling.

  2010cited by this paper
• Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells.

  2009cited by this paper
• Suppression of T cell costimulator ICOS by Δ9‐tetrahydrocannabinol

  2009cited by this paper
• Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling*

  2009cited by this paper
• CD40/CD40L signaling and its implication in health and disease

  2009cited by this paper
• CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells

  2009cited by this paper
• Comparison of T Cell Receptor-Induced Proximal Signaling and Downstream Functions in Immortalized and Primary T Cells

  2009cited by this paper
• Phylogenetic analysis of the promoter region of the CD40L gene in primates and other mammals.

  2008cited by this paper
• Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9‐tetrahydrocannabinol

  2008cited by this paper
• The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).

  2008cited by this paper
• Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

  2008cited by this paper
• Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production.

  2007cited by this paper
• Induction of intracellular calcium elevation by Δ9‐tetrahydrocannabinol in T cells involves TRPC1 channels

  2006cited by this paper
• CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.

  2006cited by this paper
• Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship

  2006cited by this paper
• 2‐Arachidonoyl‐glycerol suppresses interferon‐γ production in phorbol ester/ionomycin‐activated mouse splenocytes independent of CB1 or CB2

  2005cited by this paper
• Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

  2005cited by this paper
• Cannabinoid-based drugs as anti-inflammatory therapeutics

  2005cited by this paper
• Cannabinoid receptor‐mediated regulation of intracellular calcium by Δ9‐tetrahydrocannabinol in resting T cells

  2004cited by this paper
• Targeting CD40L: a Promising Therapeutic Approach

  2004cited by this paper
• Cannabinoids inhibit the activation of ERK MAPK in PMA/Io-stimulated mouse splenocytes.

  2003cited by this paper
• Cannabinoids: potential anticancer agents

  2003cited by this paper
• NF-kappaB activation pathways induced by T cell costimulation.

  2003cited by this paper
• NF-κB Is Involved in Regulation of CD40 Ligand Expression on Mycobacterium bovis Bacillus Calmette-Guérin-Activated Human T Cells

  2003cited by this paper
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003cited by this paper
• CD154 transcriptional regulation in primary human CD4 T cells

  2003cited by this paper
• NF-kappaB is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guérin-activated human T cells.

  2003cited by this paper
• Ca2+/calcineurin signalling in cells of the immune system.

  2003cited by this paper
• NF‐ĸB activation pathways induced by T cell costimulation

  2003cited by this paper
• Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.

  2002cited by this paper
• The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression

  2002cited by this paper
• CD28 Costimulation Mediates Down-Regulation of p27kip1 and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T Cells1

  2002cited by this paper
• Activation and inhibition of lymphocytes by costimulation.

  2002cited by this paper
• IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.

  2002cited by this paper
• IL-2 Receptor Blockade Inhibits Late, But Not Early, IFN-γ and CD40 Ligand Expression in Human T Cells: Disruption of Both IL-12-Dependent and -Independent Pathways of IFN-γ Production

  2002cited by this paper
• The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review

  2001cited by this paper
• The immunological synapse.

  2001cited by this paper
• NF‐κB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells.

  2001cited by this paper
• Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD21

  2001cited by this paper
• AP‐1 activity is negatively regulated by cannabinol through inhibition of its protein components, c‐fos and c‐jun

  2000cited by this paper
• Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.

  2000cited by this paper
• CD40‐CD40 ligand

  2000cited by this paper
• Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells.

  2000cited by this paper
• CD154 (CD40 ligand).

  2000cited by this paper
• Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation.

  1999cited by this paper
• Cannabinol-Mediated Inhibition of Nuclear Factor-k B , cAMP Response Element-Binding Protein , and Interleukin-2 Secretion by Activated Thymocytes 1

  1999cited by this paper
• Phospholipase A2 inhibitors p-bromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes

  1999cited by this paper
• Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.

  1999cited by this paper
• The CD40L Promoter Contains Nuclear Factor of Activated T Cells-binding Motifs Which Require AP-1 Binding for Activation of Transcription (*)

  1996cited by this paper
• Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2*

  1996cited by this paper
• Increase of intracellular calcium is the essential signal for the expression of CD40 ligand

  1996cited by this paper
• Human Native Soluble CD40L Is a Biologically Active Trimer, Processed Inside Microsomes (*)

  1996cited by this paper
• The Human gp39 Promoter

  1995cited by this paper
• Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.

  1995cited by this paper
• Potassium and calcium channels in lymphocytes.

  1995cited by this paper
• Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

  1994cited by this paper
• The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

  1993cited by this paper
• Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

  1992cited by this paper
• Delta 9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes.

  1992cited by this paper
• Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.

  1992cited by this paper
• Tetrahydrocannabinol stability in whole blood: plastic versus glass containers.

  1986cited by this paper
• Metabolism, disposition, and kinetics of delta‐9‐tetrahydrocannabinol in men and women

  1983cited by this paper
• Constituents of Cannabis sativa L. XVII. A review of the natural constituents.

  1980cited by this paper

• Effects of acute THC challenge on behavior and neuroinflammation in HIV-1 Tg26 mice vary based on HIV status, chronic THC history, and sex.

  2026cites this paper
• Mode of action approach supports a lack of carcinogenic potential of six organic UV filters

  2025cites this paper
• Development of an in vitro peptide-stimulated T cell assay to evaluate immune effects by cannabinoid compounds.

  2024cites this paper
• Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis

  2022cites this paper
• An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis

  2021cites this paper
• Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application.

  2021cites this paper
• An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses

  2020cites this paper
• MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages.

  2020cites this paper
• CD40 Receptor Knockout Protects against Microcystin-LR (MC-LR) Prolongation and Exacerbation of Dextran Sulfate Sodium (DSS)-Induced Colitis

  2020cites this paper
• Cannabinoids and inflammation: Implications for People Living with HIV.

  2019cites this paper
• Suppression of CpG‐ODN‐mediated IFN&agr; and TNF&agr; response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)‐specific agonists

  2019cites this paper
• miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus–Infected Rhesus Macaques

  2018cites this paper
• Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer

  2018cites this paper
• Anandamide inhibits Fc&egr;RI‐dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2‐GPR55 heteromers

  2018cites this paper
• Immunotoxicity testing using human primary leukocytes: An adjunct approach for the evaluation of human risk.

  2017cites this paper
• The Psychoneuroimmunological Influences of Recreational Marijuana

  2017cites this paper
• Endocannabinoid system modulation of the ocular immune response

  2015influential citation
• Platelet activity in the pathophysiology of inflammatory bowel diseases.

  2015cites this paper
• Immunotoxicology of Drugs of Abuse

  2014cites this paper
• Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.

  2013cites this paper